Peck, D.S.; Lacey, J.M.; White, A.L.; Pino, G.; Studinski, A.L.; Fisher, R.; Ahmad, A.; Spencer, L.; Viall, S.; Shallow, N.;
et al. Incorporation of Second-Tier Biomarker Testing Improves the Specificity of Newborn Screening for Mucopolysaccharidosis Type I. Int. J. Neonatal Screen. 2020, 6, 10.
https://doi.org/10.3390/ijns6010010
AMA Style
Peck DS, Lacey JM, White AL, Pino G, Studinski AL, Fisher R, Ahmad A, Spencer L, Viall S, Shallow N,
et al. Incorporation of Second-Tier Biomarker Testing Improves the Specificity of Newborn Screening for Mucopolysaccharidosis Type I. International Journal of Neonatal Screening. 2020; 6(1):10.
https://doi.org/10.3390/ijns6010010
Chicago/Turabian Style
Peck, Dawn S., Jean M. Lacey, Amy L. White, Gisele Pino, April L. Studinski, Rachel Fisher, Ayesha Ahmad, Linda Spencer, Sarah Viall, Natalie Shallow,
and et al. 2020. "Incorporation of Second-Tier Biomarker Testing Improves the Specificity of Newborn Screening for Mucopolysaccharidosis Type I" International Journal of Neonatal Screening 6, no. 1: 10.
https://doi.org/10.3390/ijns6010010
APA Style
Peck, D. S., Lacey, J. M., White, A. L., Pino, G., Studinski, A. L., Fisher, R., Ahmad, A., Spencer, L., Viall, S., Shallow, N., Siemon, A., Hamm, J. A., Murray, B. K., Jones, K. L., Gavrilov, D., Oglesbee, D., Raymond, K., Matern, D., Rinaldo, P.,
& Tortorelli, S.
(2020). Incorporation of Second-Tier Biomarker Testing Improves the Specificity of Newborn Screening for Mucopolysaccharidosis Type I. International Journal of Neonatal Screening, 6(1), 10.
https://doi.org/10.3390/ijns6010010